Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Non Operating Income (2023 - 2025)

Historic Non Operating Income for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $4.1 million.

  • Upstream Bio's Non Operating Income rose 4084.8% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.3 million, marking a year-over-year increase of 4771.79%. This contributed to the annual value of $15.0 million for FY2024, which is 2359.4% down from last year.
  • According to the latest figures from Q3 2025, Upstream Bio's Non Operating Income is $4.1 million, which was up 4084.8% from $4.4 million recorded in Q2 2025.
  • Upstream Bio's Non Operating Income's 5-year high stood at $6.3 million during Q3 2023, with a 5-year trough of $2.5 million in Q4 2023.
  • In the last 3 years, Upstream Bio's Non Operating Income had a median value of $4.1 million in 2024 and averaged $4.1 million.
  • Over the last 5 years, Upstream Bio's Non Operating Income had its largest YoY gain of 10328.39% in 2024, and its largest YoY loss of 5383.51% in 2024.
  • Over the past 3 years, Upstream Bio's Non Operating Income (Quarter) stood at $2.5 million in 2023, then surged by 103.28% to $5.1 million in 2024, then dropped by 19.5% to $4.1 million in 2025.
  • Its last three reported values are $4.1 million in Q3 2025, $4.4 million for Q2 2025, and $4.7 million during Q1 2025.